Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786629 · ClinicalTrials.gov registry record · Phase 4
BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects
A Phase 4 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 338
- Enrollment target
NCT01786629: Completed Phase 4 study, sponsored by Braintree Laboratories.
NCT01786629 is a Phase 4 study that has completed, run by Braintree Laboratories. The registered enrollment target is 338 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01786629, a Phase 4 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 338 participants
- Enrollment target
Study Summary
To compare the safety, tolerance and efficacy of SUPREP Bowel Prep Kit to an FDA approved control as bowel preparations prior to colonoscopy in adult patients.
Interventions
- DRUG SUPREP Bowel Prep Kit
- DRUG FDA approved bowel preparation containing electrolytes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2012-12 |
| Phase | Phase 4 |
What the finished NCT01786629 record still lists
NCT01786629 is an interventional study that assigns participants to a tested intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 2 interventions - of which SUPREP Bowel Prep Kit is the first listed.
NCT01786629 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01786629 about?
NCT01786629 is a clinical study titled "BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects". To compare the safety, tolerance and efficacy of SUPREP Bowel Prep Kit to an FDA approved control as bowel preparations prior to colonoscopy in adult patients.
What is the current status of trial NCT01786629?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 338 participants. The study started on 2012-12.
What interventions are being tested in trial NCT01786629?
The interventions under investigation include: SUPREP Bowel Prep Kit (DRUG), FDA approved bowel preparation containing electrolytes (DRUG).
Who is sponsoring clinical trial NCT01786629?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01786629's enrollment target sits among peer trials
338 249th of 2000 higher than 1,751 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia